Fil d'actualités

Filtrer
  • VIH
namsal
31
Oct
2018

Dolutegravir, an alternative first-line HIV treatment for low and middle-income countries

  • VIH
Fotolia Sondem
26
Jul
2018

AIDS 2018
Raltegravir and pregnancy - ANRS RalFE

  • VIH
  • Hépatites
Thuy Nguyen
26
Jul
2018

AIDS 2018
MSM: HCV transmission networks

  • VIH
Child
25
Jul
2018

AIDS 2018
Benefits early therapy HIV children - ANRS CLEAC

  • VIH
Parcours
25
Jul
2018

AIDS 2018
Migrants: HIV infections - ANRS Parcours

  • VIH
Clinique mobile
24
Jul
2018

AIDS 2018 - ANRS TasP
Benefits of home-based testing and local clinics in South Africa

  • VIH
Logo Prevenir
24
Jul
2018

AIDS 2018
First results from the ANRS Prevenir study:  1,500 participants, 0 infection

  • Hépatites
dépistage VHC
02
Jul
2018

Cost-effective universal screening for hepatitis C in France

  • VIH
Nouveaux schémas thérapeutiques
15
Mar
2018

Cryptococcal meningitis : validation of new therapeutic regimens

  • VIH
VIH mutant
07
Mar
2018

A mutant HIV able to replicate without integrating its DNA into cell chromosomes